An observational study of pregnancy and post‐partum outcomes in women with prolactinoma treated with dopamine agonists

Abstract

In women with prolactinoma medical treatment with dopamine agonists (DA) can restore fertility. A number of studies have established the safety of DA during pregnancy and the impact of pregnancy and lactation on remission of prolactinoma. However, the total number of reported cases remains modest and further evidence is needed.